AVR (Anteris Technologies Global) ROE % Adjusted to Book Value: -34.11% (As of Mar. 2026)


AVR Anteris Technologies Global Corp AVR
23 GF Score
Price $9.97
! 7 Warning Signs
View Full Analysis

What is Anteris Technologies Global ROE % Adjusted to Book Value?

Anteris Technologies Global AVR +1.01% 23 ROE % Adjusted to Book Value is -34.11% as of Mar. 2026. GuruFocus rates AVR with a GF Score™ of 23/100. The stock has 7 warning signs investors should review.

Anteris Technologies Global's ROE % for the quarter that ended in Mar. 2026 was -66.17%. Anteris Technologies Global's PB Ratio for the quarter that ended in Mar. 2026 was 1.94. Anteris Technologies Global's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -34.11%.

Anteris Technologies Global ROE % Adjusted to Book Value Related Terms

Anteris Technologies Global ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Anteris Technologies Global's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anteris Technologies Global ROE % Adjusted to Book Value Chart

Anteris Technologies Global Annual Data
Trend Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -57.97 0.00

Anteris Technologies Global Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -54.45 -43.99 -14.49 0.00 -34.11

AVR vs INMD, QDEL, SSII: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, Anteris Technologies Global's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anteris Technologies Global ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Anteris Technologies Global's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Anteris Technologies Global's ROE % Adjusted to Book Value falls into.


AVR
23GF Score
Anteris Technologies Global Corp AVR
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anteris Technologies Global ROE % Adjusted to Book Value Calculation

Anteris Technologies Global's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-300.45% / N/A
=N/A

Anteris Technologies Global's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-66.17% / 1.94
=-34.11%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -34.11% mean?
Anteris Technologies Global (AVR) has a ROE % Adjusted to Book Value of -34.11% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Anteris Technologies Global and its competitors.
Is Anteris Technologies Global's ROE % Adjusted to Book Value too high?
Anteris Technologies Global's current ROE % Adjusted to Book Value is -34.11%. Overall, Anteris Technologies Global has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Anteris Technologies Global's ROE % Adjusted to Book Value compare to INMD and QDEL?
Anteris Technologies Global's ROE % Adjusted to Book Value of -34.11% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Anteris Technologies Global and its competitors. Anteris Technologies Global's current ROE % Adjusted to Book Value is -34.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anteris Technologies Global stock overvalued right now?
Anteris Technologies Global (AVR) has a current ROE % Adjusted to Book Value of -34.11%. The current ROE % Adjusted to Book Value is -34.11%. Anteris Technologies Global's overall GF Score™ is 23/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Anteris Technologies Global (AVR), the current ROE % Adjusted to Book Value is -34.11% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anteris Technologies Global Business Description

Other Exchanges AVR:Australia
Address 9 Sherwood Road, Level 3, Suite 302, Toowong Tower, Toowong, QLD, AUS, 4066
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.
23GF Score

Get the complete analysis for AVR

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.97
Price